Skip to content

Preferred Stock at other companies

ALN
Alnylam PharmaceuticalsALNY
$0
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$0
Absci Corporation logo
Absci CorporationABSI
$0
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$0
Revvity logo
RevvityRVTY
$0
Biogen logo
BiogenBIIB
$0

Other financials

Income statement

See full
Revenue$8.2M-12.8%
Operating income-$11.4M-14.4%
Net income-$9.1M-3.0%
EPS (diluted)-$0.54+53.8%

Balance sheet

See full
Cash & equivalents$31.1M+32.9%
Total debt$2.5M-17.5%
Total equity$198.6M+632%
Total assets$235.5M+138%

Cash flow

See full
Operating cash flow-$22.1M+5.7%
CapEx$19.0K
Free cash flow-$22.1M+5.6%

Valuation

See full
Market cap$480.77M+262%
Enterprise value$452.14M+302%
P/S6.8×+2.6×

Profitability

See full
Operating margin-116.8%-26.1pp
Net margin-103.6%-22.7pp
FCF margin-150%-231pp

Returns & leverage

See full
Return on equity-36.9%-15.1pp
Debt / equity-0.1×
Current ratio6.6×+4.6×

Where this comes from

Reported directly by Assembly Biosciences in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockValue.

The official record: Assembly Biosciences’s 10-Q, filed May 9, 2019, on SEC EDGAR. View the filing →

Questions, answered.

What does preferred stock mean?
Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.